Stock market announcement archive

January 26, 2023
Bergen, Norway 26 Januar 2023 A new partnership with Goethe University Frankfurt am Main strengthen Lifecare'saccess to expertise and increase our recruitment base. Lifecare CSO Prof. Dr.Dr. Andreas Pfützner will present Lifecare's technology at the 16thInternational Conference on "Advanced Technologies & Treatments for Diabetes" inBerlin (ATTD 22-25 February 2023). The Norwegian Catapult Centre has awarded […]
Read more
January 5, 2023
Bergen, Norway 5 Januar 2023 2022 was a very good year for Lifecare as a company and we welcome 2023expecting continued significant progress in our mission to make life easier forpatients with diabetes. Throughout 2022 Lifecare disclosed several milestone events, read more in letterfrom Lifecare's CEO published today: https://lifecare.no/news/happy-new-year/This is Lifecare: Lifecare is a Bergen-based […]
Read more
December 6, 2022
Bergen, Norway 6.12.2022Today Lifecare announces all-time high revenue in their financial reporting forQ3 2022. - We are pleased to see a positive outcome of the investments we havemade. Furthermore, this provides a base for LifecareŽs continued research andproduct development, says CEO Joacim Holter.The consolidated group financials show a revenue of 15,4 MNOK for the first […]
Read more
December 6, 2022
Bergen, Norway 6 December 2022 Lifecare AS will present Q3 2022 financial and operational status in a webcasttoday, Tuesday 6 December. The webcast will be for all shareholders andinterested parties at 13:00 - 14:00 CET. Lifecare CEO Joacim Holter will participate in the webcast.There will be a Q&A session following the presentation. The webcast will […]
Read more
December 1, 2022
Bergen, Norway 1 December 2022 Lifecare AS will present Q3 2022 financial and operational status in a webcastTuesday 6 December. For more information of the webcast and other news, read Lifecare's latestnewsletter: https://lifecare.no/news/information-from-lifecare-november-2022/This is Lifecare: Lifecare is a Bergen-based technology company developing a miniaturizedimplantable long-term sensor for correct and continuous monitoring of bloodsugar in people […]
Read more
November 8, 2022
Lifecare has incorporated a new subsidiary, Lifecare Chemistry Ltd, located inBath, UK. - This move gives us clear strategic advantages related to chemical researchdevelopment and builds on the close and good collaboration Lifecare already hasestablished with the University of Bath, says CEO Joacim Holter.Since 2020, Lifecare has worked together with researchers at the University ofBath […]
Read more
November 3, 2022
Reference is made to the stock exchange announcement published on 26 October2022 by Lifecare AS (the "Company") announcing the successful completion of aprivate placement of new shares in the Company, with gross proceeds of NOK 45million (the "Private Placement"). The share capital increase related to the Private Placement has been registeredin the Norwegian Register of […]
Read more
November 3, 2022
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA,JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCHRELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOESNOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange announcement published on 26 October2022 by […]
Read more
October 27, 2022
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA,JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCHRELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOESNOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange announcement published on 26 October2022 by […]
Read more
October 26, 2022
Reference is made to the stock exchange announcement by Lifecare AS (the"Company") on 26 October 2022 regarding the successful placing of a privateplacement of new shares (the "Offer Shares") with gross proceeds ofapproximately NOK 45 million (the "Private Placement"). Please see the attached form for details on transactions conducted by a closelyassociated party of a […]
Read more